Patents by Inventor Mohammad Khanfar

Mohammad Khanfar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzamide compounds and related methods of use
    Patent number: 9890117
    Abstract: Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: February 13, 2018
    Assignee: Northwestern University
    Inventors: Richard B. Silverman, Hua Wang, Mohammad Khanfar, Aleksey G. Kazantsev
  • Benzamide Compounds and Related Methods of Use
    Publication number: 20170050926
    Abstract: Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.
    Type: Application
    Filed: June 20, 2016
    Publication date: February 23, 2017
    Inventors: Richard B. Silverman, Hua Wang, Mohammad Khanfar, Aleksey G. Kazantsev
  • Benzamide compounds and related methods of use
    Patent number: 9533947
    Abstract: Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.
    Type: Grant
    Filed: May 30, 2014
    Date of Patent: January 3, 2017
    Assignees: Northwestern University, The General Hospital Corporation
    Inventors: Richard B. Silverman, Hua Wang, Mohammad Khanfar, Aleksey G. Kazantsev
  • Benzamide compounds and related methods of use
    Patent number: 9371277
    Abstract: Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: June 21, 2016
    Assignees: Northwestern University, The General Hospital Corporation
    Inventors: Richard B. Silverman, Hua Wang, Mohammad Khanfar, Aleksey G. Kazantsev
  • Benzamide Compounds and Related Methods of Use
    Publication number: 20150025235
    Abstract: Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.
    Type: Application
    Filed: May 30, 2014
    Publication date: January 22, 2015
    Inventors: Richard B. Silverman, Hua Wang, Mohammad Khanfar, Aleksey G. Kazantsev
  • Benzamide Compounds and Related Methods of Use
    Publication number: 20140234939
    Abstract: Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.
    Type: Application
    Filed: December 23, 2013
    Publication date: August 21, 2014
    Applicant: Northwestern University
    Inventors: Richard B. Silverman, Hua Wang, Mohammad Khanfar
  • Latrunculin-Based Macrolides and Their Uses
    Publication number: 20110136880
    Abstract: Latrunculin derivatives are disclosed, as are anti-invasive and cytotoxic uses for latrunculins and latrunculin derivatives, and semisyntheses of latrunculin derivatives. The latrunculins and latrunculin derivatives are useful, for example, in treating cancers.
    Type: Application
    Filed: December 6, 2010
    Publication date: June 9, 2011
    Inventors: Khalid El Sayed, Mohammad Khanfar